|
|
|
We have an extensive portfolio of leading prescription medicines across a range of therapeutic areas and we are committed to research and innovation to meet the medical needs of the future. The sanofi-aventis portfolio of marketed products includes several medicines that are world leaders in their respective classes, in the areas of thrombosis, cardiometabolic diseases, diabetes, cancer, bone disease and epilepsy.
|
 |
Sanofi-aventis’ Pharmaceuticals division focuses its activities on the following major therapeutic areas: - Cardiometabolic disease
- Thrombosis
- Oncology
- General medicine (including central nervous system, bone diseases and insomnia)
To find out more about our Pharmaceutical products, click here
|
| Updated: October 12, 2009 |
|
|
 |
|
Corporate Information
Get more information about sanofi-aventis group
|
|
|
 |
|
